Kenvue Inc. (KVUE)
NYSE: KVUE · Real-Time Price · USD
18.13
-0.12 (-0.66%)
At close: Sep 16, 2025, 4:00 PM EDT
18.16
+0.03 (0.16%)
After-hours: Sep 16, 2025, 7:59 PM EDT
Kenvue Employees
Kenvue had 22,000 employees as of December 29, 2024. The number of employees did not change compared to the previous year.
Employees
22,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$688,227
Profits / Employee
$64,455
Market Cap
34.79B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 29, 2024 | 22,000 | 0 | - |
Dec 31, 2023 | 22,000 | -200 | -0.90% |
Dec 31, 2022 | 22,200 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Walmart | 2,100,000 |
PepsiCo | 319,000 |
Costco Wholesale | 316,000 |
Anheuser-Busch InBev | 143,885 |
Unilever | 120,040 |
The Procter & Gamble Company | 109,000 |
Mondelez International | 90,000 |
Philip Morris International | 83,100 |
KVUE News
- 4 days ago - Meet 16 Ideal "Safer" September Dividend Dogs Of The S&P500 - Seeking Alpha
- 4 days ago - COVID vaccine makers' shares fall as Trump officials to link shots to child deaths, report says - Market Watch
- 4 days ago - Kenvue CEO lobbied RFK Jr. not to cite Tylenol as autism cause, WSJ reports - Reuters
- 4 days ago - The CEO of Tylenol maker Kenvue lobbied RFK Jr. to not cite the over-the-counter medication as a potential cause of autism in a soon-to-be released report - WSJ
- 6 days ago - Dividend Kings: 2 Ideal Buys In 25 "Safer" Of 56 September Dogs - Seeking Alpha
- 7 days ago - What To Do With These Seven S&P 500 Stocks That Slumped - Seeking Alpha
- 8 days ago - S&P 500 Losers: From Lululemon To MGM — What Went Wrong? - Forbes
- 8 days ago - Tylenol maker's stock dips after report says RFK Jr.'s HHS plans to link the drug to autism - Fast Company